Glucocorticoid treatment and the risk of secondary adrenal insufficiency
What length of glucocorticoid treatment is associated with a risk of developing secondary adrenal insufficiency?
What length of glucocorticoid treatment is associated with a risk of developing secondary adrenal insufficiency?
If you were to name the 3 most important recent advances in endocrinology that are relevant for everyday practice, what would they be?
Dr Leonard Wartofsky from Georgetown University Hospital, United States, shares his thoughts on the 3 most important recent advances in the management of thyroid diseases.
Dr Bess Dawson-Hughes from Tufts University School of Medicine, United States, offers her view on the 3 most important recent advances in the management of osteoporosis.
Dr Hertzel Gerstein from McMaster University shares his views on the 3 most important recent advances in treating diabetes.
Dr Dror Dicker from Tel Aviv University shares his views on the 3 most important recent advances in treating obesity.
Does levothyroxine therapy reduce the risk of pregnancy loss in thyroid peroxidase antibody (TPOAb)-positive euthyroid women who are newly pregnant?
What is the appropriate treatment in patients with severe hypothyroidism and myxedema coma? What thyroid hormones should be administered (T4 and T3 administered together or separately)? What dosing should be used?
What are the key diagnostic criteria for myxedema coma? What signs and symptoms are the most alarming?